Overview
Legal name
VIVISCO LIMITED
Region
London
Registered address
7 BELL YARD
LONDON
ENGLAND
WC2A 2JR
Insolvency history
No
Company
Active
LTD
Company profile
Vivisco Limited
Google Translate
Google's service, offered free of charge, instantly translates words, phrases, and web pages between English and over 100 other languages.
CRN
12149068
Founded
2019
Age
6
Latest accounts
Financial period: 1 Sep 2024 to 9 Jul 2025
FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
1
Company events
Reference milestones and recent Companies House filing stream events.
6 events
09 Apr
2027
Accounts due
Accounts DueNext accounts due date
05 Oct
2026
Confirmation statement due
Confirmation DueNext confirmation statement due date
21 Sep
2025
Confirmation statement filed
ConfirmationLast confirmation statement made up date
09 Jul
2025
Accounts filed
AccountsLast accounts made up date
01 Oct
2024
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQzNzk1OTQ0N2FkaXF6a2N4
Published 01 Oct 2024 12:16
09 Aug
2019
Incorporated
InceptionCompany registered at Companies House
Public funding
2 awards
First funded
2020
Funded years
2020, 2023
Age at first award
0 years
Projects
2023
Collaborative R&D
Lead participant
Quantified assessment of the closed-loop sterilization capabilities of Vivisco’s UVC Sterilizer
1 Sep 2023 to 30 Nov 2023
Awarded
£7,200
Total cost £7,200
Vivisco Limited is manufacturing on demand, UVC Sterilizers for closed-loop fluidic systems. These systems are found in (pre-) clinical and bioscience studies in applications including, but not limited to electrophysiology, imaging and pharmacology. However, these studies can be limited by bacterial and viral loads in the solution contaminating the test s...
2020
Feasibility Studies
Lead participant
Next generation minimally invasive photodynamic therapy for treating COVID-19
1 Jun 2020 to 30 Nov 2020
Awarded
£49,491
Total cost £49,491
We are developing the next generation of medical devices which activate light-sensitive drugs. We will use these medical devices to enable light-activated drugs to be used as a treatment of COVID-19\.
Product types
Collaborative R&D
Feasibility Studies